Clinical Trials Directory

Trials / Recruiting

RecruitingNCT06389071

Laser Treatment for Lichen Sclerosus

Safety and Efficacy of Ablative Fractional 2940 nm Laser Treatment for Lichen Sclerosus Lesion

Status
Recruiting
Phase
N/A
Study type
Interventional
Enrollment
50 (estimated)
Sponsor
Sciton · Industry
Sex
Female
Age
18 Years
Healthy volunteers
Accepted

Summary

Fractional ablative laser treatment for Lichen Sclerosus lesion

Conditions

Interventions

TypeNameDescription
DEVICEFractional 2940 nm LaserFractional 2940 nm Laser

Timeline

Start date
2024-03-01
Primary completion
2025-12-20
Completion
2025-12-30
First posted
2024-04-29
Last updated
2025-05-15

Locations

1 site across 1 country: Canada

Source: ClinicalTrials.gov record NCT06389071. Inclusion in this directory is not an endorsement.

Laser Treatment for Lichen Sclerosus (NCT06389071) · Clinical Trials Directory